Company / Capital Expenditures
Prime Medicine, Inc. Capital Expenditures History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$7.3M
FY2024
5-year range
$639.0K / $16.1M
FY2020-FY2024
Trend
-16.4%
vs FY2023
Sector context
#66 of 195
Health Care
What the data says
At $7M, Prime Medicine, Inc.'s capital expenditures ranks #66 of 195 in the Health Care sector. Declined from $16M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2024 with a 3-year CAGR of +20.7%.
Declined from $16M to $7M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +20.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#66 of 195 in Health CareTop 34% of 195This company $7.3M Sector average $117.2M
▼
-93.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +20.7%, indicating consistent growth.
- In FY2024, capital expenditures decreased 16.4% year-over-year.
- Ranks #66 out of 195 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.3M | -16.4% |
| FY2023 | $8.7M | -45.8% |
| FY2022 | $16.1M | +287.8% |
| FY2021 | $4.2M | +549.5% |
| FY2020 | $639.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026